In the complex, globalized world of pharmaceuticals, clear communication is a matter of patient safety. MedDRA (the Medical Dictionary for Regulatory Activities) is the critical, standardized terminology that ensures a “heart attack” in a report from Japan is understood identically by a regulator in Europe. This article explores how this universal language powers pharmacovigilance, enables precise signal detection, and forms the backbone of international drug regulation from clinical trials to post-market surveillance.
What is MedDRA?
MedDRA is a comprehensive, standardized, international medical terminology used specifically for the regulation of health products throughout their entire life cycle, from development to post-market monitoring. It is the common language that allows regulators and pharmaceutical companies worldwide to accurately share, analyze, and monitor data.
Think of MedDRA as a universal medical dictionary designed to ensure that when a doctor in Japan reports a side effect and a regulator in Europe analyzes it, they are both describing the same medical condition in the same way, even if they speak different languages.
1. Who Created It and Why?
- Creator: The International Council for Harmonisation (ICH). The ICH is a global initiative that brings together regulatory authorities and the pharmaceutical industry from Europe, Japan, the USA, and other regions to standardize drug development and regulation.
- The Problem: Before MedDRA, different organizations used different medical terminologies. This made it difficult to:
- Pool and compare data from international clinical trials.
- Share safety reports between companies and regulators.
- Analyze long-term safety data efficiently.
Converting between terminologies was time-consuming, expensive, and led to data loss or distortion.
- The Solution: ICH created MedDRA to be a single, standardized terminology for all regulatory activities, eliminating the need for multiple dictionaries.
2. Key Features and Benefits of MedDRA
- Hierarchical Structure: MedDRA is organized into five levels, from very specific to very general. This allows for both detailed and high-level analysis.
- LLT (Lowest Level Term): The most specific term, as reported (e.g., “Runny nose”).
- PT (Preferred Term): A single, standardized concept for a symptom, diagnosis, etc. (e.g., “Rhinorrhoea”).
- HLT (High Level Term): Groups related PTs (e.g., “Nasal signs and symptoms”).
- HLGT (High Level Group Term): Broader groups of HLTs (e.g., “Upper respiratory tract signs and symptoms”).
- SOC (System Organ Class): The highest level, categorizing terms by body system or etiology (e.g., “Respiratory, thoracic, and mediastinal disorders”).
- Multiaxiality: A single term can appear in more than one SOC. For example, “Influenza” is primarily in the Infections and Infestations SOC but is also linked to the Respiratory disorders SOC. This is crucial for comprehensive analysis.
- Multilingual: Each MedDRA term has a unique numerical code. The code remains the same across all languages. This allows a user in France and a user in Japan to share and understand data perfectly because they are using the same code.
- Standardised MedDRA Queries (SMQs): These are pre-defined, validated groups of MedDRA terms used to search for specific safety concerns.
- Example: Instead of manually searching for every term related to “liver failure,” a user can run the “Drug-related hepatic disorders – comprehensive” SMQ, which automatically retrieves all relevant PTs (like “Hepatitis,” “Jaundice,” “Liver function test increased”). This is a powerful tool for signal detection in pharmacovigilance.
- Electronic Communication: MedDRA is essential for the electronic exchange of Individual Case Safety Reports (ICSRs), which are reports of adverse drug reactions. It ensures that the medical information in these reports is structured and unambiguous.
3. How is MedDRA Governed and Maintained?
- Governance: The MedDRA Management Board, overseen by ICH, is responsible for the strategic direction and integrity of MedDRA. The board includes representatives from major regulatory agencies and industry associations.
- Maintenance: The Maintenance and Support Services Organization (MSSO) handles the day-to-day maintenance. This includes:
- Updating MedDRA twice a year to include new medical terms.
- Managing user subscriptions and providing support.
- A Japanese Maintenance Organization (JMO) provides support for Japanese users.
- User Input: Subscribers can submit “change requests” to propose new terms or updates, ensuring MedDRA stays current with medical science.
4. Who Uses MedDRA and How Much Does It Cost?
- Users:
- Regulatory Authorities: Like the FDA (USA), EMA (Europe), and PMDA (Japan). Its use is mandatory in the EU and Japan for regulatory reporting and is the de facto standard in the US.
- Pharmaceutical Companies: For clinical trials, safety monitoring, and regulatory submissions.
- Researchers and Healthcare Providers.
- Cost:
- Free for government regulators.
- Low or no cost for non-profit organizations, academics, and healthcare providers.
- Sliding scale fees for commercial companies based on their revenue.
Practical Example in Pharmacovigilance:
- A patient in Spain reports “dolor de cabeza fuerte” (severe headache) after taking a new drug. A local doctor codes this as an LLT in Spanish.
- The pharmaceutical company receives the report. The unique MedDRA code allows their system in the UK to automatically display the corresponding PT: “Migraine.”
- A pharmacovigilance scientist wants to check if there is a signal for neurological issues. They run the “Headaches” SMQ, which aggregates data from all PTs related to headaches, including “Migraine,” “Tension headache,” etc., from reports worldwide.
- This standardized data allows the scientist and regulators to quickly see if “Migraine” is occurring more frequently than expected, enabling rapid safety decisions.
Conclusion
MedDRA is the backbone of modern drug regulation and pharmacovigilance. It is not just a dictionary but a sophisticated, living terminology that enables efficient data sharing, powerful analysis, and, ultimately, better patient safety on a global scale. Its structured, multilingual, and well-maintained nature makes it an indispensable tool for protecting public health.
